The Gillette Company v. S.C. Johnson & Son, Inc.

919 F.2d 720, 16 U.S.P.Q. 2d (BNA) 1923, 1990 U.S. App. LEXIS 20138, 1990 WL 181238
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 20, 1990
Docket90-1320
StatusPublished
Cited by48 cases

This text of 919 F.2d 720 (The Gillette Company v. S.C. Johnson & Son, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The Gillette Company v. S.C. Johnson & Son, Inc., 919 F.2d 720, 16 U.S.P.Q. 2d (BNA) 1923, 1990 U.S. App. LEXIS 20138, 1990 WL 181238 (Fed. Cir. 1990).

Opinion

RICH, Circuit Judge.

This appeal is from the July 31, 1989 judgment of the U.S. District Court for the District of Massachusetts (Collings, U.S. M.), 1 holding claims 1, 3, 8-10, 12-18 and 21-23 of Patent No. 3,541,581 to Monson on a shaving preparation not invalid under 35 USC 103 and infringed by the Gillette Company (Gillette). See Gillette Co. v. S.C. Johnson & Son, Inc., 12 USPQ2d 1929, 1989 WL 87374 (D.Mass.1989), reconsider *721 ation denied, 15 USPQ2d 1795, 1990 WL 36143 (D.Mass.1990). Gillette appeals only on validity and does not contest infringement. We affirm.

I. BACKGKOUND

S.C. Johnson & Son (Johnson) is assignee of the Monson patent, which issued November 17, 1970 and is now expired. Although the patent title is “Package Containing A Post-Foaming Gel,” the claims are drawn to a “stable, post-foaming gel” composition. The term “post-foaming” means that the claimed composition remains a gel as it is expelled from its container but foams up after it is spread over the user’s skin. Johnson has marketed a commercial embodiment of the claimed composition under the well-known EDGE trademark since 1970.

Although claims 1, 3, 8-10, 12-18 and 21-23 are appealed, claim 1 is representative and will suffice for our purposes. Claim 1 reads:

1. A cleansing or cosmetic composition in the form of a stable, post-fo[a]ming gel consisting essentially of about 40-90% by weight water, about 4-25% by weight water-soluble soap, about 0.5-12% by weight volatile liquid post-foaming agent selected from the group consisting of saturated aliphatic hydrocarbons, halogenated hydrocarbons and mixtures thereof, and about 0.01-5% by weight of at least one water-soluble gelling agent which forms in said composition, a gel having a yield value sufficiently high to substantially restrain said composition from foaming for at least about 60 seconds, under static ambient conditions.

The controversy here revolves around the “water-soluble gelling agent” component of the claimed composition, which according to Monson's specification can be chosen from “water-soluble derivatives of naturally occurring substances such as cellulose, sucrose and glucose.” As further disclosed by Monson, the gelling agent functions to modify the consistency of the composition by imparting “yield value,” or flow resistance. The resulting solid state properties of the gel restrain its foaming for a desired period of time, i.e., for about 60 seconds at 63° F. and one atmosphere. In preferred embodiments of the claimed composition wherein the gelling agent is a cellulose derivative, the water-soluble gelling agent also functions to enhance lubricity, allowing the shaving blade to glide across the user’s skin with reduced friction.

During prosecution of the application for the Monson patent, the Patent and Trademark Office (PTO) examiner initially rejected the claims as obvious in view of Estig-nard-Bluard (Bluard) (U.S. Patent No. 2,995,521) and Friedenberg (U.S. Patent No. 3,240,396). Bluard discloses a “self-foaming” composition which can be formulated to have the consistency of a cream; gel-based compositions are not disclosed. Like Monson’s, Bluard’s composition can be thought of as “post-foaming” in that it spontaneously foams when spread over a user’s skin. It includes soap, water, and foaming agent, as does Monson’s. However, Bluard’s composition does not contain a water-soluble gelling agent; he uses an oii-soluble “jellifying” agent, namely aluminum octoate. Bluard discloses that when saponaceous [i.e., soapy] compositions having the consistency of a cream are used (for example, shaving creams), it is preferable to “thicken the organic liquid [foaming agent] by means of a jellifying agent,” in order to “avoid any separation of the organic liquid and the thick sapona-ceous composition during storage or use.... ” Thus, Bluard’s jellifying agent is intended to thicken the organic phase, not the aqueous phase, of his self-foaming composition.

Friedenberg discloses that colloidal materials including certain cellulose derivatives are useful as stabilizers in shaving creams or shampoos formulated as “very dilute emulsions” of at least 75%, preferably 85%, water. Friedenberg does not disclose the use of these colloidal materials in a gel-based composition, nor in a post-foaming composition.

British Patent Specification No. 838,913 to Colgate-Palmolive (Colgate) was also cited by the examiner to “show the state of the art.” Colgate discloses the addition of *722 colloidal materials such as cellulose derivatives to “soap solutions of low concentration,” so as to stabilize the lather of the disclosed “aerosol shave creams.”

The examiner initially took the position that it would have been obvious to one skilled in the art to “substitute the claimed jellifying agents, i.e. colloids,” for the jelli-fying agent [aluminum octoate] shown in Bluard, in view of Friedenberg, “who show[s] said agents are well known for the same purpose in the same type of compositions[,] i.e. forming shaving compositions.”

In response to the initial rejection, Johnson submitted results of consumer testing in which the formulation of Example 1 of Monson was unanimously preferred by a panel of shavers over a modified Monson formulation wherein Bluard’s aluminum oc-toate had been substituted for the claimed water-soluble gelling agent. A second panel unanimously preferred the Monson formulation over a “self-foaming shaving cream” formulated according to Example 11 of Bluard. Eight out of nine members of a third panel preferred the Monson formulation over another “self-foaming shaving cream” formulated according to Example 10 of Bluard. After considering these showings, the examiner allowed the Mon-son application. 2 Johnson’s resulting EDGE gel product went on to become an overwhelming commercial success; the district court found that EDGE accounted for more than 20% of the market for shaving products at the time of trial. Gillette, 12 USPQ2d at 1962.

Johnson sued Gillette on September 1, 1983, in the Northern District of Illinois, charging infringement of the Monson patent by Gillette’s “Foamy Gel” product. Gillette in turn brought a declaratory judgment action of invalidity and. unenforceability against Johnson in the District of Massachusetts. The Illinois action was transferred to Massachusetts and consolidated with the suit there, where trial took place. After the bench trial, Magistrate Codings held in a very thorough opinion that Gillette had failed to prove that the Monson patent was invalid on the ground of obviousness, that Gillette had infringed by its manufacture, use, and sale of “Foamy Gel,” that the infringement was willful, and that the case was “exceptional” under 35 USC 285, such that the court was authorized to award attorney fees to Johnson. Id. at 1964. Gillette then moved for reconsideration of the decision. In his memorandum opinion of March 28, 1990, fully answering Gillette’s arguments, Magistrate Codings denied Gillette’s motion and reaffirmed his holdings. See 15 USPQ2d at 1795. This appeal followed. Damages have yet to be determined.

This court previously upheld the validity of the Monson patent in S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Supernus Pharmaceuticals, Inc. v. TWi Pharmaceuticals, Inc.
265 F. Supp. 3d 490 (D. New Jersey, 2017)
Wbip, LLC v. Kohler Co.
829 F.3d 1317 (Federal Circuit, 2016)
ProBatter Sports, LLC v. Sports Tutor, Inc.
172 F. Supp. 3d 579 (D. Connecticut, 2016)
ActiveVideo Networks, Inc. v. Verizon Communications, Inc.
807 F. Supp. 2d 544 (E.D. Virginia, 2011)
Callaway Golf Co. v. Acushnet Co.
523 F. Supp. 2d 388 (D. Delaware, 2007)
Sanofi-Synthelabo v. Apotex Inc.
492 F. Supp. 2d 353 (S.D. New York, 2007)
Pfizer v. Apotex (Formerly Known as Torpharm)
488 F.3d 1377 (Federal Circuit, 2007)
Abbott Laboratories v. Sandoz, Inc.
500 F. Supp. 2d 807 (N.D. Illinois, 2007)
Mars, Inc. v. Coin Acceptors, Inc.
478 F. Supp. 2d 689 (D. New Jersey, 2007)
Syntex (u.s.a.) Llc v. Apotex
Federal Circuit, 2005
nCUBE Corp. v. SeaChange International, Inc.
313 F. Supp. 2d 361 (D. Delaware, 2004)
Vectra Fitness, Inc. v. Icon Health & Fitness, Inc.
288 F. Supp. 2d 1155 (W.D. Washington, 2003)
National Steel Car, Ltd. v. Canadian Pacific Railway, Ltd.
254 F. Supp. 2d 527 (E.D. Pennsylvania, 2003)
Trustees of Columbia University v. Roche Diagnostics GmbH
272 F. Supp. 2d 90 (D. Massachusetts, 2002)
Lucent Technologies, Inc. v. Newbridge Networks Corp.
168 F. Supp. 2d 269 (D. Delaware, 2001)
Basic American, Inc. v. Shatila
992 P.2d 175 (Idaho Supreme Court, 1999)
McGinley v. Franklin Sports, Inc.
75 F. Supp. 2d 1218 (D. Kansas, 1999)
Braintree Laboratories, Inc. v. Nephro-Tech, Inc.
58 F. Supp. 2d 1293 (D. Kansas, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
919 F.2d 720, 16 U.S.P.Q. 2d (BNA) 1923, 1990 U.S. App. LEXIS 20138, 1990 WL 181238, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-gillette-company-v-sc-johnson-son-inc-cafc-1990.